PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 1, 20248 citations

#88 Lenvatinib plus pembrolizumab versus chemotherapy as first-line therapy for advanced or recurrent endometrial cancer: primary results of the phase 3 ENGOT-en9/LEAP-001 study

View Full Paper
Ask AI
Bookmark
Share

Authors

CMChristian MarthRMRichard G. MooreMBMariusz Bidziński

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Marth et al. (2024) studied this question.

synapsesocial.com/papers/68e761c9b6db6435876d7ea8https://doi.org/10.1136/ijgc-2024-esgo.1115
View Full Paper
Ask AI
Bookmark
Share